Seletalisib Terminated Phase 2 Trials for Primary Sjögren's Syndrome (pSS) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02610543UCB Proof of Concept Study in Patients With Primary Sjögren's Syndrome